PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $16,596,000 | -4.5% | 5,268,663 | -11.8% | 0.00% | 0.0% |
| Q2 2020 | $17,385,000 | +95.3% | 5,974,200 | +89.2% | 0.00% | 0.0% |
| Q1 2020 | $8,903,000 | -17.0% | 3,156,957 | -4.5% | 0.00% | 0.0% |
| Q4 2019 | $10,728,000 | +46.2% | 3,306,012 | -2.7% | 0.00% | 0.0% |
| Q3 2019 | $7,340,000 | -65.7% | 3,398,172 | -50.2% | 0.00% | -50.0% |
| Q2 2019 | $21,415,000 | -9.6% | 6,820,171 | +7.1% | 0.00% | 0.0% |
| Q1 2019 | $23,696,000 | +28.9% | 6,369,872 | +0.5% | 0.00% | 0.0% |
| Q4 2018 | $18,380,000 | -5.6% | 6,337,916 | -14.4% | 0.00% | +100.0% |
| Q3 2018 | $19,476,000 | +1.3% | 7,405,856 | -9.9% | 0.00% | -50.0% |
| Q2 2018 | $19,229,000 | -13.4% | 8,216,760 | +8.9% | 0.00% | 0.0% |
| Q1 2018 | $22,192,000 | -5.5% | 7,547,056 | -11.9% | 0.00% | 0.0% |
| Q4 2017 | $23,475,000 | -2.9% | 8,567,070 | +20.1% | 0.00% | 0.0% |
| Q3 2017 | $24,182,000 | +94.1% | 7,132,369 | +41.5% | 0.00% | +100.0% |
| Q2 2017 | $12,457,000 | +24.4% | 5,042,207 | +14.4% | 0.00% | 0.0% |
| Q1 2017 | $10,012,000 | +10.6% | 4,409,212 | +3.3% | 0.00% | 0.0% |
| Q4 2016 | $9,052,000 | -31.2% | 4,269,317 | +8.8% | 0.00% | 0.0% |
| Q3 2016 | $13,153,000 | +11.7% | 3,925,331 | +4.7% | 0.00% | 0.0% |
| Q2 2016 | $11,775,000 | -3.0% | 3,747,570 | +2.8% | 0.00% | 0.0% |
| Q1 2016 | $12,140,000 | -4.4% | 3,645,532 | +1.6% | 0.00% | 0.0% |
| Q4 2015 | $12,704,000 | -27.1% | 3,588,682 | +3.6% | 0.00% | -50.0% |
| Q3 2015 | $17,427,000 | -28.4% | 3,465,332 | -8.5% | 0.00% | -33.3% |
| Q2 2015 | $24,355,000 | -8.9% | 3,787,368 | -0.4% | 0.00% | 0.0% |
| Q1 2015 | $26,744,000 | -3.9% | 3,801,910 | +5.4% | 0.00% | 0.0% |
| Q4 2014 | $27,821,000 | +7.0% | 3,607,661 | +3.6% | 0.00% | 0.0% |
| Q3 2014 | $25,999,000 | -25.2% | 3,480,713 | -3.1% | 0.00% | -25.0% |
| Q2 2014 | $34,770,000 | +14.3% | 3,591,951 | -1.9% | 0.00% | +33.3% |
| Q1 2014 | $30,426,000 | -43.0% | 3,661,399 | -46.8% | 0.00% | 0.0% |
| Q4 2013 | $53,344,000 | +91.2% | 6,883,527 | +96.7% | 0.00% | 0.0% |
| Q3 2013 | $27,899,000 | +5.4% | 3,500,022 | +2.1% | 0.00% | 0.0% |
| Q2 2013 | $26,475,000 | – | 3,429,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |